Title: Once-yearly zoledronic acid in older men compared with women with recent hip fracture
Authors: Boonen, Steven ×
Orwoll, Eric
Magaziner, Jay
Colón-Emeric, Cathleen S
Adachi, Jonathan D
Bucci-Rechtweg, Christina
Haentjens, Patrick
Kaufman, Jean-Marc
Rizzoli, Rene
Vanderschueren, Dirk
Claessens, Frank
Sermon, An
Witvrouw, Richard
Milisen, Koen
Su, Guoqin
Lyles, Kenneth W
HORIZON Recurrent Fracture Trial #
Issue Date: Nov-2011
Publisher: Williams & Wilkins
Series Title: Journal of the American Geriatrics Society vol:59 issue:11 pages:2084-90
Article number: 10.1111/j.1532-5415.2011.03666.x
Abstract: To assess the efficacy of once-yearly zoledronic acid (ZOL) 5 mg in increasing bone mineral density (BMD) in men with a recent hip fracture participating in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once- Yearly Recurrent Fracture Trial and to compare the efficacy with that in women from the same study.
ISSN: 0002-8614
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
Academic Center for General Practice
Laboratory of Molecular Endocrinology
Interdepartmental Platform Hospital Care
Academic Centre for Nursing and Midwifery
Gerontology and Geriatrics
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science